DRRX | DURECT Corporation
Industry: Drug Manufacturers - Other Quick infos Headquarters: Cupertino, California, United States Trade prices Volume: Market Cap: 102.84M Prev closed: 0.73 Open: 0.73 High: 0.77 Low: 0.73 52 week low: 0.46 52 week high: 2.55 Dividends: No Dividends Next ER: August 4, 2022 After Market Closes
Company Profile DURECT is a biopharmaceutical company actively developing therapeutics based on its Epigenetic Regulator Program and proprietary drug delivery platforms.
Earnings History Date EPS / Forecast Revenue / Forecast November 7, 2022 August 4, 2022 -0.05 / -0.04672.08M / 3.84MMay 5, 2022 -0.05 / -0.05331.92M / 2.28MMay 4, 2022 -0.05 / -0.04331.92M / 3.87MMarch 7, 2022 -0.03 / -0.04677.3M / 2.1MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 4, 2022 0.6300 0.6000 0.6380
0.5821
608.54K 7.12% Aug 3, 2022 0.5881 0.5600 0.6000
0.5500
565.09K 8.93% Aug 2, 2022 0.5399 0.5248 0.5500
0.5101
758.13K 4.43% Aug 1, 2022 0.5170 0.4900 0.5180
0.4760
444.61K 5.51% Jul 29, 2022 0.4900 0.4635 0.4995
0.4400
889.18K 10.86% Jul 28, 2022 0.4420 0.4500 0.4580
0.4280
448.16K 0.80% Jul 27, 2022 0.4385 0.4600 0.4600
0.4260
458.23K 3.18% Jul 26, 2022 0.4250 0.4539 0.4600
0.4210
318.90K -4.28% Jul 25, 2022 0.4440 0.4440 0.4647
0.4367
392.26K 0.91% Jul 22, 2022 0.4400 0.4400 0.4410
0.4366
605.87K -3.49% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US2666051048 CUSIP: 266605104 Founded:1998 News
DURECT Corporation Announces Second Quarter 2020 Financial Results and Update of Programs finance.yahoo.com Aug 13, 2020 4:05 pm
DRRX: DUR-928 Programs Accelerating. Anticipate NASH, Psoriasis Data Later This Year finance.yahoo.com Aug 13, 2020 4:00 pm Durect's stock tumbles after failed psoriasis trial marketwatch.com Aug 13, 2020 10:08 am
The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex finance.yahoo.com Aug 13, 2020 8:20 am Durect up 12% after Q2 beat, launch of mid-stage study of DUR-928 in COVID-19 seekingalpha.com Aug 4, 2020 7:22 pm Durect EPS beats by $0.06, beats on revenue seekingalpha.com Aug 4, 2020 4:08 am Durect Corp (DRRX) Q2 2020 Earnings Call Transcript fool.com Aug 4, 2020 1:00 am Here's Why Shares of Durect Jumped Higher Today fool.com Aug 1, 2020 2:20 pm Biopharma Durect shares halted ahead of FDA committee meeting on post-surgical pain treatment marketwatch.com Aug 1, 2020 7:24 am Is It Too Late to Buy These 3 Pharmaceutical Stocks? fool.com Jul 7, 2020 7:35 am Gilead terminates agreement with DURECT seekingalpha.com Jun 27, 2020 5:34 am
Top Pharmaceutical Stocks for Q3 2020 investopedia.com Jun 11, 2020 2:45 pm
The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares finance.yahoo.com Aug 13, 2020 8:07 am
DURECT Corporation Trading Halted Today; FDA Advisory Committee to Discuss POSIMIR® (bupivacaine extended-release solution) for Post-Surgical Analgesia finance.yahoo.com Aug 13, 2020 7:05 am
DURECT Corp. to Host Earnings Call finance.yahoo.com Aug 13, 2020 6:30 am
Oppenheimer: These 3 Strong Buy Stocks Could Double, If Not More finance.yahoo.com Aug 5, 2020 3:31 pm
Durect (DRRX) Q2 Earnings and Revenues Beat Estimates finance.yahoo.com Aug 3, 2020 6:35 pm
DURECT Corporation Announces First Quarter 2019 Financial Results and Update of Programs finance.yahoo.com Aug 1, 2020 5:42 pm
DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs finance.yahoo.com Aug 1, 2020 4:05 pm
DURECT Corporation (DRRX): Hedge Funds Are Nibbling finance.yahoo.com Aug 1, 2020 10:37 am This company doesn't provide a dividend.
Talk about DURECT Corporation below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
